SCHEMBL1385202

SCHEMBL1385202

COC[C@H]1CN(S(=O)(=O)c2cc3ccc(Cl)cc3s2)CC(=O)N1CC1CCN(c2ccnc(N(C)C)n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.43
F2 P00734 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1385994 0.90 F10 (0.44) F10F2
SCHEMBL1386661 0.89 F10 (0.47) F10
SCHEMBL4385748 0.88 F10 (0.53) F10
SCHEMBL1386783 0.85 KCNH2 (0.40) F10
SCHEMBL1385907 0.84 F10 (0.54) F10F2
SCHEMBL1385505 0.84 F10 (0.39) F10
SCHEMBL1385080 0.84 KCNH2 (0.45) F10
SCHEMBL1385204 0.77 F10 (0.39) F10F2
SCHEMBL1386867 0.76 F10 (0.55) F10F2
SCHEMBL8112808 0.75 KDM4E (0.42) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4829449-B2 2011-12-07 JP claimed
JP-2003508353-A 2003-03-04 JP claimed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP claimed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO claimed
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 US disclosed